Pividl Bioscience develops proprietary nanobiotechnology platforms that enhance product efficacy across the global health and wellness, consumer packaged goods, agrifood, and pharmaceutical sectors. Their technologies address the need for improved delivery systems and bioavailability of active ingredients, leading to more effective and sustainable solutions.
Funding
$40K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many active ingredients in health and wellness, consumer packaged goods, agrifood, and pharmaceutical products suffer from poor delivery and bioavailability, limiting their efficacy and requiring higher dosages for desired effects. This can lead to increased costs, reduced product performance, and potential environmental or health concerns.
Solution
Pividl Bioscience develops proprietary nanobiotechnology platforms designed to enhance the delivery and bioavailability of active ingredients across various sectors. Their technologies aim to improve product efficacy, reduce required dosages, and create more sustainable solutions. By encapsulating active ingredients within nanoscale carriers, Pividl's platforms protect them from degradation, improve their absorption, and enable targeted delivery to specific sites of action. This approach leads to enhanced product performance, reduced waste, and improved outcomes for consumers and businesses.
Target Audience
Pividl Bioscience targets companies in the global health and wellness, consumer packaged goods, agrifood, and pharmaceutical industries seeking to improve the performance and sustainability of their products through advanced delivery systems.
Features
- Nanoscale encapsulation of active ingredients for enhanced protection and delivery
- Customizable platform technologies adaptable to diverse product formulations
- Improved bioavailability and absorption of active ingredients
- Targeted delivery mechanisms for site-specific action
- Enhanced product efficacy with reduced dosage requirements
- Sustainable solutions with minimized environmental impact